Prime Therapeutics - Processing Update for Blue Cross Blue Shield of Alabama - Immediate Release Opioids Initial Fill Limit

Effective April 1, 2018

Author: Erica Lawrence/Friday, March 16, 2018/Categories: APCI Choice

Effective April 1, 2018, Blue Cross Blue Shield Alabama "BCBSAL" will be implementing an utilization management program which limits the duration of therapy of immediate release opioids, including single and combination agents. Initial fills of these agents will be limited to 7 days of therapy. A prescription quantity that exceeds a 7-day supply will require prior authorization.

*Please see attached for more information*

Comments are only visible to subscribers.